Think global trial supply is just FDA compliance? Customs rules, local sourcing mandates, climate extremes, and regional regulations say otherwise.
- Forecast Vs. Actual: Why Protocol Design Breaks Clinical Supply Plans
- AI In Clinical Trial Supply Chains
- Clinical Trial Supply Lessons From Ebola Outbreak Response
- Global Labeling And Packaging In Complex Supply Environments
- Addressing Reverse Logistics In Clinical Supply Chains: Turning Complexity Into Strategic Advantage
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- Clinical Supply Chains For Decentralized Trials In Sub-Saharan Africa
- What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Hidden Benefits Of Clinical Forecasting & Supply Planning Solutions
Streamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.
-
Common RTSM/IRT AN Medication Pooling Questions Answered
Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Investigational Medicinal Products: Labeling Changes And Their Implications
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
GMP Clinical Storage Strategies for Today's Complex Trials
Temperature‑sensitive therapies need more than basic freezer space. Purpose‑built GMP storage protects product integrity, supports compliance, and adds flexibility as trial complexity grows.
-
Considerations When Selecting An Interactive Response Technology Provider
Interactive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain
In an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.
-
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study
Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
Complex Randomization Delivered Successfully
Learn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.